patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · small molecule
DYANAVEL XR 20
Marketedupdated 2mo agoby $TRAW Traws Pharma, Inc.🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for attention deficit hyperactivity disorder and 3 investigational indications.
targets
Sodium-dependent dopamine transporterSodium-dependent noradrenaline transporter
all catalysts(6)
approval · 6
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that